Category: Align Technology Inc.
An International Trade Commission judge finds that Pakistani dental device maker ClearCorrect infringes 7 Align Technology patents.
Align Technology (NSDQ:ALGN) said a judge with the International Trade Commission found that Pakistani dental device maker ClearCorrect and a U.S. affiliate infringe 7 of Align's patents.
Dental devices maker Align Technologies gains almost 5% on Wall Street after reporting adjusted per-share earnings about 30% higher than analysts' expectations.
Align Technology (NSDQ:ALGN) got a big Wall Street boost today after reporting a big increase in sales and strong growth in shipments of its flagship Invisalign product.
Align Technology got an 8.5% boost on Wall Street today after the company released its Q4 2012 earnings report, beating analysts' estimates with record Invisalign shipments during the year.
Orthodontic devices maker Align Technology (NSDQ:ALGN) won big points on Wall Street today after releasing a strong 4th quarter earnings report, beating expectations and issuing optimistic projections for 2013.
MassDevice.com looks back at the voices, which made headlines in the medical device industry in 2012
|
"We play a critical role in managing and moving market share. I think the device sector has not necessarily acknowledged the role of the GPOs, but I think increasingly, as products mature in particular, GPOs play a vital role in helping to drive market share up on behalf of a supplier." -- Novation CEO Jody Hatcher
|
The MassDevice Big 100 West, a conversation of medical device company leaders, in pictures.
MassDevice held its 2nd annual Big 100 Roundtable West event in Newport Beach, Calif., December 11. A group of nearly med-tech executives and stakeholders gathered for an evening of networking, insight into medical device marketing and intimate interviews with David Pyott, CEO of Allergan; Tom Prescott, CEO of Align Technology; James Mazzo, president of Abbott Medical Optics; and Robert Grant, chairman and Strathspey Crown.
Abbott Medical Optics president James Mazzo with CHI co-founder David Gollaher.
